Task: Answer the multiple-choice question.
Query: Which drug exhibits a -17.926% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) CCOc1cc(C(=O)OCC(=O)Nc2ccc(SC(F)F)cc2)cc(OCC)c1OCC
b.) Cc1ccc(S(=O)(=O)N(C)c2ccc(OCC(=O)Nc3nc(-c4ccccc4)cs3)cc2)cc1
c.) O=C(CSc1nnc(-c2c[nH]c3ccccc23)o1)N1c2ccccc2CCc2ccccc21
d.) O=c1[nH]nnc2c1sc1nc(N3CCOCC3)c3c(c12)CCCC3
e.) CCCc1cc(=O)oc2cc(OCC(=O)NCCCN3CCOCC3)ccc12
Answer: e. CCCc1cc(=O)oc2cc(OCC(=O)NCCCN3CCOCC3)ccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1cc(=O)oc2cc(OCC(=O)NCCCN3CCOCC3)ccc12
CCCc1cc(=O)oc2cc(OCC(=O)NCCCN3CCOCC3)ccc12
N-(3-morpholin-4-ylpropyl)-2-(2-oxo-4-propylchromen-7-yl)oxyacetamide